Roche announces positive results for Actemra in phase III study

VIENNA, Nov 13 (Reuters) - Swiss drugmaker Roche

said on Sunday its rheumatoid arthritis medication Actemra for

giant cell arteritis showed to be superior to steroids alone in

maintaining...

Read more